BRidging Information Divides and Gaps to Ensure Survivorship: the BRIDGES Randomized Controlled Trial of a Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
弥合信息鸿沟和差距,确保生存:旨在提高儿童癌症生存依从性的多层次干预的 BRIDGES 随机对照试验
基本信息
- 批准号:10491902
- 负责人:
- 金额:$ 57.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-21 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAgeBlack raceCOVID-19 pandemicCancer CenterCancer SurvivorshipCaringChemotherapy and/or radiationClinicCollaborationsCommon Terminology Criteria for Adverse EventsCommunicationCommunitiesConsensusDiagnosisDissemination and ImplementationEducationElectronic Health RecordEligibility DeterminationEnrollmentEnsureExplosionGoalsGoldGuidelinesHealthInstitutionInsuranceInteractive CommunicationInterventionInterviewKnowledgeLate EffectsLatinxLifeMaintenanceMalignant Childhood NeoplasmMalignant NeoplasmsMedical RecordsMethodsModelingMonitoring for RecurrenceOncologistOutcomePatient CarePatient EducationPatient-Focused OutcomesPatientsPersonsPhysiciansPrimary Health CareProcessQuality of CareRandomizedRandomized Controlled TrialsRecommendationResourcesRuralSamplingSelf EfficacyServicesSiteStructureSubgroupSurveysTechnologyTelephoneTestingText MessagingTravelVisitWorkacceptability and feasibilityadherence ratearmbasecancer therapycare providerschildhood cancer survivorcommunity centercomparison groupcostfollow-upfuture implementationhealth disparityimprovedindividual patientinnovationinstrumentintervention participantsmedical specialtiespatient health informationpatient portalpreferenceprimary endpointprimary outcomeprogramsprovider-level barrierssocioeconomic disadvantagesurvivorshiptelehealthtumor
项目摘要
PROJECT SUMMARY
More than 80% of childhood cancer survivors (CCS) develop serious or life-threatening late effects. Yet <20%
of CCS receive recommended survivorship care, despite the availability of consensus guidelines for lifelong
surveillance for late effects starting 2 years post-therapy. The “gold standard” cancer center-based survivorship
clinic provides high-quality care to CCS who attend, but patients avoid reminders of their past cancer and lack
knowledge and self-efficacy for survivorship care. Other barriers include travel distance, inadequate insurance,
and out-of-pocket costs—these structural issues contribute to health disparities. Partnering with community
primary care provider (PCP) clinics in a shared model of care is a promising strategy to overcome these barriers,
but PCPs lack knowledge, self-efficacy, and interactive communication with the cancer center and are confused
about the division of care responsibilities. Our intervention is scalable and distance-based, is informed directly
by patient and PCP barriers and preferences from previous studies, and is boosted by a nationwide explosion in
telehealth services precipitated by the COVID-19 crisis. The proposed randomized controlled trial will enroll 240
CCS 2.0-4.0 years post-chemotherapy/radiation to investigate an innovative multi-level intervention (i.e.,
interpersonal and organizational levels) consisting of 1) patient survivorship education via telehealth with the
cancer center, 2) ongoing patient-tailored education program within the EHR's patient portal, 3) a structured
interactive phone communication between the cancer center and the PCP clinic (with 1-year follow-up call), and
4) an in-person visit with the PCP clinic for survivorship care. The comparison group will be randomized to an
in-person visit with their cancer center survivorship clinic. This study includes 4 centers with high proportions of
subgroups vulnerable to survivorship care disparities (i.e., rural, Black, Latinx, Spanish-speaking,
socioeconomically disadvantaged). Both groups will be asked to begin recommended surveillance for late effects
within 1-year post-randomization, separate from tumor recurrence monitoring by the primary oncologist. Our
Specific Aims are to Aim 1- Demonstrate patient completion of guideline-recommended surveillance tests in
intervention participants is not inferior, i.e. within 10%, to that in the comparison group; Aim 2- Achieve greater
1) patient knowledge, self-efficacy, and activation and 2) PCP knowledge and self-efficacy with survivorship care
among intervention participants and their PCPs compared to the comparison group; and Aim 3- Ascertain
process outcomes for the 1) patient and 2) PCP clinic. Outcomes will also be assessed among subgroups with
survivorship care disparities. Transformative Impact: If our intervention demonstrates patient completion of
recommended survivorship care comparable to cancer center survivorship clinic, our study has the enormous
potential to deliver recommended lifelong care to a larger proportion of CCS and reduce survivorship care
disparities, while engaging patients and PCPs to integrate survivorship care as part of overall, lifelong health
maintenance.
项目总结
超过80%的儿童癌症幸存者(CCS)会出现严重或危及生命的后遗症。但仍有20%
的CCS接受建议的生存护理,尽管有一致的终身指导方针
从治疗后2年开始监测远期效应。以癌症中心为基础的“黄金标准”生存
诊所为参加CCS的人提供高质量的护理,但患者避免提醒他们过去的癌症和缺乏
生存护理的知识和自我效能。其他障碍包括旅行距离、保险不足、
和自付费用--这些结构性问题导致了健康差距。与社区合作
共享护理模式中的初级保健提供者(PCP)诊所是克服这些障碍的一种有前途的战略,
但PCP缺乏知识,缺乏自我效能,缺乏与癌症中心的互动交流,感到困惑
关于护理责任的分工。我们的干预是可扩展的、基于远程的、直接通知的
由患者和PCP障碍和之前研究的偏好决定,并受到全国范围内的爆炸性增长的推动
新冠肺炎危机催生的远程医疗服务。拟议的随机对照试验将有240人参加
CCS在化疗/放疗后2.0-4.0年研究创新的多水平干预(即,
人际和组织层面)包括:1)通过远程健康教育患者的生存
癌症中心,2)在EHR的患者门户内持续的患者定制教育计划,3)结构化的
癌症中心和初级保健诊所之间的互动电话交流(包括为期一年的跟踪电话),以及
4)亲临PCP诊所接受生存护理。对照组将被随机分成一组
亲临他们的癌症中心生存诊所。这项研究包括4个比例较高的中心
易受生存护理差异影响的亚群(即农村人、黑人、拉丁裔、西班牙语、
在社会经济上处于不利地位)。两组都将被要求开始推荐的晚期效应监测
在随机化后的1年内,与初级肿瘤学家监测的肿瘤复发分开。我们的
具体目标是目标1-证明患者完成了指南建议的监测测试
干预参与者并不比对照组差,即在10%以内;目标2-达到更大
1)患者知识、自我效能和激活度;2)PCP知识和生存护理自我效能
与对照组比较的干预参与者及其初级合作伙伴;以及目标3--确定
为1)患者和2)PCP诊所处理结果。还将在分组中评估结果,包括
生存护理方面的差距。变革性影响:如果我们的干预证明患者完成了
推荐的生存护理堪比癌症中心的生存诊所,我们的研究具有巨大的
向更大比例的CCS提供建议的终身护理并减少生存护理的可能性
差异,同时让患者和初级保健医生将生存护理整合为整体终身健康的一部分
维修。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NINA S KADAN-LOTTICK其他文献
NINA S KADAN-LOTTICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NINA S KADAN-LOTTICK', 18)}}的其他基金
Developing and Testing a Culturally Tailored Mobile Health and Social MediaPhysical Activity Intervention Among Adolescent and Young Adult ChildhoodCancer Survivors
开发和测试针对青少年和青年儿童癌症幸存者的文化定制移动健康和社交媒体体育活动干预
- 批准号:
10736526 - 财政年份:2023
- 资助金额:
$ 57.72万 - 项目类别:
BRidging Information Divides and Gaps to Ensure Survivorship: the BRIDGES Randomized Controlled Trial of a Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
弥合信息鸿沟和差距,确保生存:旨在提高儿童癌症生存依从性的多层次干预的 BRIDGES 随机对照试验
- 批准号:
10274932 - 财政年份:2021
- 资助金额:
$ 57.72万 - 项目类别:
BRidging Information Divides and Gaps to Ensure Survivorship: the BRIDGES Randomized Controlled Trial of a Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
弥合信息鸿沟和差距,确保生存:旨在提高儿童癌症生存依从性的多层次干预的 BRIDGES 随机对照试验
- 批准号:
10910674 - 财政年份:2021
- 资助金额:
$ 57.72万 - 项目类别:
A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
对青少年和青年儿童癌症幸存者进行移动健康和社交媒体体育活动干预的随机试验
- 批准号:
10020359 - 财政年份:2019
- 资助金额:
$ 57.72万 - 项目类别:
A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
对青少年和青年儿童癌症幸存者进行移动健康和社交媒体体育活动干预的随机试验
- 批准号:
10464453 - 财政年份:2019
- 资助金额:
$ 57.72万 - 项目类别:
A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
对青少年和青年儿童癌症幸存者进行移动健康和社交媒体体育活动干预的随机试验
- 批准号:
10706322 - 财政年份:2019
- 资助金额:
$ 57.72万 - 项目类别:
A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
对青少年和青年儿童癌症幸存者进行移动健康和社交媒体体育活动干预的随机试验
- 批准号:
9895223 - 财政年份:2019
- 资助金额:
$ 57.72万 - 项目类别:
BONE DENSITY IN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
小儿急性淋巴细胞白血病幸存者的骨密度
- 批准号:
6264297 - 财政年份:1998
- 资助金额:
$ 57.72万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 57.72万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 57.72万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 57.72万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 57.72万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 57.72万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 57.72万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 57.72万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 57.72万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 57.72万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 57.72万 - 项目类别:
Directed Grant














{{item.name}}会员




